Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDIV 1

Study Type

Interventional 9Observational 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Lung Neoplasms 1Colorectal Neoplasms 1Adenocarcinoma 1

Interventions

Blood Specimen Collection 17Pancreaticoduodenectomy 15Surveys and Questionnaires 11Endoscopic Ultrasound-Guided Fine Needle Aspiration 10Observation 9Biopsy 8Specimen Handling 6Pancreatectomy 6Gemcitabine 6Endosonography 6Data Collection 6Surgical Procedures, Operative 5Magnetic Resonance Spectroscopy 5Electroporation 5Biopsy, Fine-Needle 5Neoadjuvant Therapy 4Magnetic Resonance Imaging 4Liquid Biopsy 4Interviews as Topic 4Immunologic Techniques 4Immunohistochemistry 4Drug Therapy 4folfirinox 3Fluorouracil 3Cholangiopancreatography, Endoscopic Retrograde 3Albumin-Bound Paclitaxel 3irinotecan sucrosofate 2Taxes 2Sulfonylurea Compounds 2Secretin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Pancreatic Neoplasms × sargramostim × Clear all
NCT03695835 2020-07-22

NIRPA

Gary Onik MD

Completed
27 enrolled
GastrointestinalGenitourinaryThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡